Position in BMY
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$969,975
+$244,177 QoQ
Shares Held
16,834
+40.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.27%
of 13F equity value
Holder Rank
#1,182
of 2,506 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 1%
Shared 0%
None 99%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Diversified Enterprises, LLC holds $20,838,520 across 11 Drug Manufacturers - General names. BMY ranks #5 (4.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
5,682 | $6,815,161 | |
| 2 | JNJ |
Johnson & Johnson
|
17,605 | $4,471,141 | |
| 3 | ABBV |
AbbVie Inc.
|
12,729 | $3,203,125 | |
| 4 | MRK |
Merck & Co., Inc.
|
14,584 | $1,874,044 | |
| 5 | BMY |
Bristol Myers Squibb Co
This page
|
16,834 | $969,975 | |
| 6 | AZN |
Astrazeneca PLC
|
4,654 | $882,491 | |
| 7 | PFE |
Pfizer Inc
|
31,160 | $750,332 | |
| 8 | AMGN |
Amgen Inc
|
1,842 | $667,025 |
All Filings in BMY
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $969,975 | 16,834 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $725,798 | 11,967 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $508,869 | 9,434 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $354,891 | 7,869 | Shares | Sole | 2025-10-10 | |
| 2025-06-30 | $372,032 | 8,037 | Shares | Sole | 2025-07-16 | |
| 2025-03-31 | $309,280 | 5,071 | Shares | Sole | 2025-05-15 | |
| No filing history on record for this holder in this stock. | ||||||